top of page

Immuno-monitoring for immuno-oncology                                  biomarker research

  • T-Cell Subset Analysis 

  • Tumor infiltrating Lymphocytes(TIL) Analysis

  • Phagocytosis 

  • PD1/PD1-L Blockade Assay 

  • IDO-1, 2 inhibitor Screening Assay 

  • Immune Checkpoint Molecule Array 

  • Antibody-Dependent Cell Cytotoxicity(ADCC)

  • Complement-Dependent Cytotoxicity(CDC)

  • Mast Cell Histamine Release 

  • Chemotaxis(T cells, Neutrophils)

  • Cytokine Release Syndrome(CRS) Risk Assessment

  • Immunogenicity Risk Assessment

  • Receptor Occupancy 

bottom of page